Related Experiment Video

Updated: Aug 7, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Overview of resistant gram-positive pathogens in the surgical patient

R P Rapp1

  • 1Division of Pharmacy Practice and Science, University Hospital, University of Kentucky Medical School, Lexington, KY 40536-0082, USA. rprapp01@pop.uky.edu

Surgical Infections
|February 22, 2003
PubMed

Insights

Drug-resistant Staphylococci and Enterococci are a major threat in surgical infections. Prudent antibiotic use is crucial to combat rising resistance, especially for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE).

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Staphylococci and enterococci are leading causes of surgical-site and bloodstream infections.
  • The rise of antibiotic resistance in these gram-positive bacteria presents a significant clinical challenge.
  • Methicillin/oxacillin resistance in Staphylococcus aureus (MRSA) is common and often linked to multidrug resistance.

Purpose of the Study:

  • To highlight the growing threat of antibiotic resistance in common Gram-positive pathogens.
  • To discuss the implications of emerging resistance to key antibiotics like vancomycin.
  • To emphasize the need for strategies to combat antimicrobial resistance.

Main Methods:

  • Review of current literature on antibiotic resistance trends in Staphylococci and Enterococci.
  • Analysis of the clinical impact of drug-resistant pathogens.
  • Examination of factors contributing to the emergence of resistance.

Main Results:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasing, with some strains showing intermediate vancomycin sensitivity.
  • Vancomycin resistance is prevalent in Enterococci (VRE), leading to higher mortality rates.
  • Third-generation cephalosporins and anti-anaerobic drugs are associated with VRE and MRSA prevalence.

Conclusions:

  • Prudent use of existing antibiotics is essential to combat drug-resistant Gram-positive pathogens.
  • Reducing vancomycin usage and other implicated agents may help prevent resistance.
  • Effective infection control and antibiotic stewardship are vital to mitigate patient risk.

More Related Videos

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants11:35

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...